Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06246526 · ClinicalTrials.gov registry record · NA

Real-World Efficacy of Evoke® Closed-loop Spinal Cord Stimulation (CL-SCS) Therapy in Chronic Pain Patients (ULTRA).

A NA study of Pain and Chronic Pain, sponsored by Saint Francis Hospital.

Active
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT06246526 is a NA study of Pain and Chronic Pain that is active but no longer recruiting, run by Saint Francis Hospital. The registered enrollment target is 25 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06246526, a NA study of Pain and Chronic Pain, is active but no longer recruiting, sponsored by Saint Francis Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

This observational, prospective data collection is designed to evaluate the efficacy of CL-SCS therapy in real-world patients suffering from chronic pain.

Interventions

  • DEVICE Evoke

Study Locations (1)

West Virginia

  • The Spine and Nerve Center of Saint Francis Hospital - Charleston

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2024-01-30
Est. Completion 2026-12-31
Phase NA

Sponsor

Saint Francis Hospital

3 total trials

What the Registry Record Tells You About NCT06246526

The ClinicalTrials.gov registry entry for NCT06246526 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (92% lower). The listed sponsor is Saint Francis Hospital, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Pain appearing as the primary indexed condition, and to 1 intervention - of which Evoke is the first listed.

NCT06246526 reports 1 study location spanning 1 distinct geographic area - top geographies include West Virginia.

Frequently Asked Questions

What is clinical trial NCT06246526 about?

NCT06246526 is a clinical study titled "Real-World Efficacy of Evoke® Closed-loop Spinal Cord Stimulation (CL-SCS) Therapy in Chronic Pain Patients (ULTRA).". This observational, prospective data collection is designed to evaluate the efficacy of CL-SCS therapy in real-world patients suffering from chronic pain.

What is the current status of trial NCT06246526?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2024-01-30. Estimated completion is 2026-12-31.

What conditions does trial NCT06246526 study?

This clinical trial studies the following conditions: Pain, Chronic Pain, Neuropathic Pain.

What interventions are being tested in trial NCT06246526?

The interventions under investigation include: Evoke (DEVICE).

Who is sponsoring clinical trial NCT06246526?

This trial is sponsored by Saint Francis Hospital, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06246526 being conducted?

This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.